Emory helps lead research on drug to treat COVID-19 patients
Emory played a leading role in the government-sponsored clinical trial of the COVID-19 drug remdesivir, hailed by Dr. Anthony Fauci as the new standard of care for hospitalized patients. Emory enrolled more patients than any other study site in the world.
RSSRecent News Releases »
Faculty Opinion »
The metric that could tell us when it’s safe to reemerge
Time well spent: How researchers can stay productive in the time of Covid-19
Opinion: Health systems working together to combat COVID
We need a better understanding of the human costs of our containment efforts for COVID-19
The critical issue Congress must include in the next COVID-19 funding package
Featured Expert »
Andra Gillespie, Politics
Political scientist Andra Gillespie specializes in political mobilization and race and is the author of "The New Black Politician: Cory Booker, Newark and Post-Racial America."
Video »
How customized antibiotic combinations could defeat 'superbugs'
A sneaky form of antibiotic resistance called "heteroresistance" is more widespread than previously appreciated. But tracking heteroresistance might guide the choice of antibiotic combinations that can defeat bacteria regarded as invincible.
Emory in the News »
Memorial Day distance: How to safely socialize with family and friends
Good Morning America, May 22
How the pandemic is changing shopping
Washington Post, May 21
US births fall, and coronavirus could drive them down more
Fox News, May 21
Study: Antibodies providing immunity
ABC, May 20
- Emory President Claire E. Sterk on the opioid crisis
